Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04392739 · ClinicalTrials.gov registry record · Phase 4
Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG
A Phase 4 study, sponsored by SIGA Technologies.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT04392739 is a Phase 4 study that has completed, run by SIGA Technologies. The registered enrollment target is 34 participants.
The verdict
NCT04392739, a Phase 4 study, has completed, sponsored by SIGA Technologies.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
Safety and PK study in adults weighing more than 120 kg
Interventions
- DRUG Tpoxx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-07-19 |
| Est. Completion | 2019-12-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04392739
The ClinicalTrials.gov registry entry for NCT04392739 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SIGA Technologies, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tpoxx is the first listed.
NCT04392739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04392739 about?
NCT04392739 is a clinical study titled "Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG". Safety and PK study in adults weighing more than 120 kg
What is the current status of trial NCT04392739?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2019-07-19. Estimated completion is 2019-12-05.
What interventions are being tested in trial NCT04392739?
The interventions under investigation include: Tpoxx (DRUG).
Who is sponsoring clinical trial NCT04392739?
This trial is sponsored by SIGA Technologies, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.